Fahey Sandell Jacquelyn — SEC Form 4 filings

SEC reporting owner CIK 1984647. 4 Form 4 filings on record with FilingPulse; latest filed 2025-02-24.

Transaction summary — filings shown

Covers all 4 filings on record, filed 2024-02-16 to 2025-02-24. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Voyager Therapeutics, Inc. (VYGR)Chief Legal Officer42 legs · 10,357 sh · $54,3074

Form 4 filings — Fahey Sandell Jacquelyn

FiledFormIssuerReported transactionsSource
2025-02-244Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 41,500 @ $0 · Grant/award (A): 83,000 (derivative) @ $0EDGAR
2025-02-124Voyager Therapeutics, Inc. (VYGR)Sale (S): 4,358 @ $4.45EDGAR
2024-10-034Voyager Therapeutics, Inc. (VYGR)Sale (S): 5,999 @ $5.82EDGAR
2024-02-164Voyager Therapeutics, Inc. (VYGR)Grant/award (A): 31,000 @ $0 · Grant/award (A): 62,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1984647 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →